IL8 (or CXCL8) was originally cloned as a factor attracting and activating neutrophils, eosinophils, and T lymphocytes [46], and as such, it has been shown to enhance tumor angiogenesis and growth through recruitment of neutrophils to the primary tumor site [53]. The gene discussed is CXCL8; the disease is neoplasm.